Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07526675 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer

Study acronym: Bioblation
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Apr 20, 2026 → Apr 20, 2027
See other at-risk trials from Benha University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Apr 20, 2026 to Apr 20, 2027 Show 5 more changesShow less
    • Recruitment opened
    • Study completion pushed from Apr 28, 2026 to Apr 28, 2027
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 4 of 5 entries
    • Site details revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Benha University
124 trials monitored
See 3 trials at risk
Prostate Cancer
2,546 trials monitored
See 172 trials at risk
This prospective study aims to validate the clinical outcomes of performing a concomitant trans-perineal prostate biopsy and laser ablation (termed "Bioblation") during a single session. The intervention is designed for symptomatic patients presenting with lower urinary tract symptoms (LUTS) who are highly suspected to have low to favorable intermediate-risk prostate cancer. By combining diagnosis and targeted treatment under local anesthesia, this approach seeks to facilitate early relief of severe symptoms and a rapid return to daily activities. Ultimately, the study evaluates whether this combined procedure decreases the patient's exposure to multiple, temporally separated interventions without compromising oncological safety or efficacy.
Trial Details
NCT Number NCT07526675
Lead Sponsor Benha University
Conditions
(from sponsor)		 Prostate Cancer, Lower Urinary Tract Symptoms (LUTS), Benign Prostatic Hyperplasia
Related terms Lower Urinary Tract Symptoms, Prostatic Hyperplasia, Prostatic Neoplasms
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov